"An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials.
Publication
, Journal Article
Fatola, O; Corneli, A; Perry, B; Hanlen-Rosado, E; Nsonwu, A; Constantine, EP; Thompson, AB
Published in: J Pediatric Infect Dis Soc
May 30, 2022
Our study explores the understanding of vaccine-induced seropositivity (VISP) and its potential impact on US adolescents' and caregivers' willingness to participate in adolescent HIV vaccine clinical trials. Findings from in-depth interviews suggest that addressing concerns about VISP will be essential for future pediatric HIV vaccine trials in the United States.
Duke Scholars
Published In
J Pediatric Infect Dis Soc
DOI
EISSN
2048-7207
Publication Date
May 30, 2022
Volume
11
Issue
5
Start / End Page
221 / 224
Location
England
Related Subject Headings
- United States
- Humans
- Health Knowledge, Attitudes, Practice
- HIV Infections
- Child
- Adolescent
- AIDS Vaccines
- 3213 Paediatrics
- 3207 Medical microbiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Fatola, O., Corneli, A., Perry, B., Hanlen-Rosado, E., Nsonwu, A., Constantine, E. P., & Thompson, A. B. (2022). "An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials. J Pediatric Infect Dis Soc, 11(5), 221–224. https://doi.org/10.1093/jpids/piac001
Fatola, Omolayo, Amy Corneli, Brian Perry, Emily Hanlen-Rosado, Adora Nsonwu, Evangelia P. Constantine, and Amelia B. Thompson. “"An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials.” J Pediatric Infect Dis Soc 11, no. 5 (May 30, 2022): 221–24. https://doi.org/10.1093/jpids/piac001.
Fatola O, Corneli A, Perry B, Hanlen-Rosado E, Nsonwu A, Constantine EP, et al. "An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials. J Pediatric Infect Dis Soc. 2022 May 30;11(5):221–4.
Fatola, Omolayo, et al. “"An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials.” J Pediatric Infect Dis Soc, vol. 11, no. 5, May 2022, pp. 221–24. Pubmed, doi:10.1093/jpids/piac001.
Fatola O, Corneli A, Perry B, Hanlen-Rosado E, Nsonwu A, Constantine EP, Thompson AB. "An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials. J Pediatric Infect Dis Soc. 2022 May 30;11(5):221–224.
Published In
J Pediatric Infect Dis Soc
DOI
EISSN
2048-7207
Publication Date
May 30, 2022
Volume
11
Issue
5
Start / End Page
221 / 224
Location
England
Related Subject Headings
- United States
- Humans
- Health Knowledge, Attitudes, Practice
- HIV Infections
- Child
- Adolescent
- AIDS Vaccines
- 3213 Paediatrics
- 3207 Medical microbiology